These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38634273)

  • 1. In vitro and in silico investigation of FDA-approved drugs to be repurposed against Alzheimer's disease.
    Akkaya D; Seyhan G; Sari S; Barut B
    Drug Dev Res; 2024 May; 85(3):e22184. PubMed ID: 38634273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound-Assisted Synthesis of Piperidinyl-Quinoline Acylhydrazones as New Anti-Alzheimer's Agents: Assessment of Cholinesterase Inhibitory Profile, Molecular Docking Analysis, and Drug-like Properties.
    Munir R; Zaib S; Zia-Ur-Rehman M; Hussain N; Chaudhry F; Younas MT; Zahra FT; Tajammul Z; Javid N; Dera AA; Ogaly HA; Khan I
    Molecules; 2023 Feb; 28(5):. PubMed ID: 36903376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinesterases inhibition and molecular modeling studies of piperidyl-thienyl and 2-pyrazoline derivatives of chalcones.
    Shah MS; Khan SU; Ejaz SA; Afridi S; Rizvi SUF; Najam-Ul-Haq M; Iqbal J
    Biochem Biophys Res Commun; 2017 Jan; 482(4):615-624. PubMed ID: 27865835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential alternatives to current cholinesterase inhibitors: an
    Kundu D; Dubey VK
    Drug Dev Ind Pharm; 2021 Jun; 47(6):919-930. PubMed ID: 34219594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug repurposing for Alzheimer's disease:
    Kumar N; Gahlawat A; Kumar RN; Singh YP; Modi G; Garg P
    J Biomol Struct Dyn; 2022 Apr; 40(7):2878-2892. PubMed ID: 33170091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid Quinoline-Thiosemicarbazone Therapeutics as a New Treatment Opportunity for Alzheimer's Disease‒Synthesis, In Vitro Cholinesterase Inhibitory Potential and Computational Modeling Analysis.
    Zaib S; Munir R; Younas MT; Kausar N; Ibrar A; Aqsa S; Shahid N; Asif TT; Alsaab HO; Khan I
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing of FDA-approved drugs as dual-acting MAO-B and AChE inhibitors against Alzheimer's disease: An in silico and in vitro study.
    Mateev E; Kondeva-Burdina M; Georgieva M; Zlatkov A
    J Mol Graph Model; 2023 Jul; 122():108471. PubMed ID: 37087882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico and in vitro studies confirm Ondansetron as a novel acetylcholinesterase and butyrylcholinesterase inhibitor.
    Gholami A; Minai-Tehrani D; Eriksson LA
    Sci Rep; 2023 Jan; 13(1):643. PubMed ID: 36635365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational Studies on Acetylcholinesterase Inhibitors: From Biochemistry to Chemistry.
    Bagri K; Kumar A; Manisha ; Kumar P
    Mini Rev Med Chem; 2020; 20(14):1403-1435. PubMed ID: 31884928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease.
    Son M; Park C; Rampogu S; Zeb A; Lee KW
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The exploration of novel Alzheimer's therapeutic agents from the pool of FDA approved medicines using drug repositioning, enzyme inhibition and kinetic mechanism approaches.
    Hassan M; Raza H; Abbasi MA; Moustafa AA; Seo SY
    Biomed Pharmacother; 2019 Jan; 109():2513-2526. PubMed ID: 30551512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer's Disease.
    Hussein W; Sağlık BN; Levent S; Korkut B; Ilgın S; Özkay Y; Kaplancıklı ZA
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30110946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of ligand-based pharmacophore modeling and docking approach to find novel acetylcholinesterase inhibitors for treating Alzheimer's.
    Dhanjal JK; Sharma S; Grover A; Das A
    Biomed Pharmacother; 2015 Apr; 71():146-52. PubMed ID: 25960230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrimidine-morpholine hybrids as potent druggable therapeutics for Alzheimer's disease: Synthesis, biochemical and in silico analyses.
    Zaib S; Younas MT; Khan I; Ali HS; McAdam CJ; White JM; Jaber F; Awwad NS; Ibrahium HA
    Bioorg Chem; 2023 Dec; 141():106868. PubMed ID: 37738768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico repurposing of antipsychotic drugs for Alzheimer's disease.
    Kumar S; Chowdhury S; Kumar S
    BMC Neurosci; 2017 Oct; 18(1):76. PubMed ID: 29078760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microwave-Assisted Synthesis of (Piperidin-1-yl)quinolin-3-yl)methylene)hydrazinecarbothioamides as Potent Inhibitors of Cholinesterases: A Biochemical and In Silico Approach.
    Munir R; Zia-Ur-Rehman M; Murtaza S; Zaib S; Javid N; Awan SJ; Iftikhar K; Athar MM; Khan I
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33513837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis and Biological Evaluation of New Cycloalkyl Fused Quinolines Tethered to Isatin Schiff Bases as Cholinesterase Inhibitors.
    Macha B; Kulkarni R; Garige AK; Palabindala R; Akkinepally R; Garlapati A
    Comb Chem High Throughput Screen; 2022; 25(1):167-186. PubMed ID: 33308120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer's Disease.
    Iman K; Mirza MU; Mazhar N; Vanmeert M; Irshad I; Kamal MA
    CNS Neurol Disord Drug Targets; 2018 Apr; 17(1):54-68. PubMed ID: 29336270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Natural Compounds of the Apple as Inhibitors against Cholinesterase for the Treatment of Alzheimer's Disease: An In Silico Molecular Docking Simulation and ADMET Study.
    Jamal QMS; Khan MI; Alharbi AH; Ahmad V; Yadav BS
    Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.